SCHEMBL714160

SCHEMBL714160

C(=Cc1ccccn1)c1ccc2ccccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.60
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
ATM Q13315 2/20 0.59
PTGS1 P23219 2/20 0.53
PTGS2 P35354 1/20 0.51
MAPT P10636 4/20 0.50
ALDH1A1 P00352 3/20 0.50
NQO2 P16083 2/20 0.50
GLA P06280 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
IP6K1 Q92551 1/20 0.49
GRM4 Q14833 1/20 0.47
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30379049 1.00 RELA (0.60) RELANPC1RAB9AMEN1KMT2A
SCHEMBL714159 1.00 RELA (0.60) RELANPC1RAB9AMEN1KMT2A
SCHEMBL12884279 0.93 NPC1 (0.59) RELANPC1RAB9AMEN1KMT2A
SCHEMBL715858 0.89 RELA (0.52) RELANPC1RAB9AMEN1KMT2A
SCHEMBL715859 0.89 RELA (0.52) RELANPC1RAB9AMEN1KMT2A
SCHEMBL16070464 0.86 NPC1 (0.53) RELANPC1RAB9AMEN1KMT2A
SCHEMBL14399195 0.85 NQO2 (0.55) RELANPC1RAB9AMEN1KMT2A
SCHEMBL710102 0.84 NPC1 (0.67) NPC1RAB9AMEN1KMT2AATM
SCHEMBL710103 0.84 NPC1 (0.67) NPC1RAB9AMEN1KMT2AATM
SCHEMBL711532 0.83 NPC1 (0.52) RELANPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1107063-B1 Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates DU PONT (US) 2010-03-10 EP claimed
US-6864039-B2 Such as naphthylvinyl-pyridine; for improved heat stability and image resolution E.I. DU PONT DE NEMOURS AND COMPANY (US) 2005-03-08 US claimed
CN-116120224-A Synthesis method of chiral beta-aza-arene tertiary carbon center compound 河南工业大学 2023-05-16 CN disclosed
US-8124625-B2 enhancing the expression of apoAI; prevention or therapy of dislipidemia SHIONOGI & CO., LTD. (JP) 2012-02-28 US disclosed
US-8053445-B2 Utilities of olefin derivatives SHIONOGI & CO., LTD. (JP) 2011-11-08 US disclosed
EP-1107063-B1 Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates DU PONT (US) 2010-03-10 EP disclosed
US-20090036457-A1 Utilities of olefin derivatives YAMAMORI TERUO 2009-02-05 US disclosed
US-7320834-B2 Organic light emitting diode containing a novel Ir complex as a phosphorescent emitter NATIONAL TSING HUA UNIVERSITY (TW) 2008-01-22 US disclosed
US-20050227109-A1 Organic light emitting diode containing a novel Ir complex as a phosphorescent emitter CHIEN-HONG CHENG (TW) 2005-10-13 US disclosed
US-6864039-B2 Such as naphthylvinyl-pyridine; for improved heat stability and image resolution E.I. DU PONT DE NEMOURS AND COMPANY (US) 2005-03-08 US disclosed
US-20040242615-A1 Utilities of olefin derivatives SHIONOGI & CO., LTD. (JP) 2004-12-02 US disclosed
US-20030219681-A1 Photobleachable compounds for use in flexographic printing plates CHENG LAP KIN (US) 2003-11-27 US disclosed
EP-1107063-A1 Photobleachable compounds containing photopolymerizable compositions for use in flexographic printing plates E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242615-A1 Utilities of olefin derivatives APOL1, NR1H2, APOB RELA 2662/4885NPC1 19/4885RAB9A 4723/4885
US-20090036457-A1 Utilities of olefin derivatives APOL1, APOB, NR1H2 RELA 3456/4885NPC1 48/4885RAB9A 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.